|
|
||||||||
2-Glycoprotein-I-Specific T Lymphocytes Is Associated with Thrombosis and Fetal Loss in Patients with Antiphospholipid Antibodies
We wish to withdraw the results of the paper by Sudha
Visvanathan, Carolyn L. Geczy, Jason A. Harmer, and H. Patrick McNeil,
"Monocyte Tissue Factor Induction by Activation of
2-Glycoprotein-I-Specific T Lymphocytes Is Associated
with Thrombosis and Fetal Loss in Patients with Antiphospholipid
Antibodies," The Journal of Immunology
2000;165:22582262. The first author of the original manuscript, Sudha
Visvanathan, has declined to sign the correction letter.
In the above article, we reported that blood mononuclear cells from
patients with the antiphospholipid syndrome (APS) expressed high levels
of tissue factor (TF) when stimulated with plasma-purified
2-glycoprotein-I (
2GPI) in vitro, whereas
little or no TF was induced when blood from patients without the APS or
healthy controls was tested. Subsequent experiments using recombinant
2GPI and a range of different preparations of purified
2GPI have shown much more variable and less consistent
results than those we reported. After extensive testing, we feel that
differences are unlikely to be due to contaminating endotoxin in some
of the preparations. Although an explanation for the discrepancy
remains unclear, we can no longer conclude that
2GPI is
the cause of the observed TF induced on mononuclear cells from patients
with APS, and for this reason, we wish to withdraw the results reported
in this manuscript.
H. Patrick McNeil
Inflammation Research Unit
School of Medical Sciences
University of New South Wales
Sydney, Australia
Carolyn L. Geczy
Jason A. Harmer
Cytokine Research Unit
School of Medical Sciences
University of New South Wales
Sydney, Australia
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |